High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients’ sera
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The characterization of peptides bound to human leukocyte antigen (HLA) class I is of fundamental importance for understanding CD8+ T cell‐driven immunological processes and for the development of immunomodulatory therapeutic strategies. However, until now, the mass spectrometric analysis of HLA‐bound peptides has typically required billions of cells, still resulting in relatively few high‐confidence peptide identifications. Capitalizing on the recent developments in mass spectrometry and bioinformatics, we have implemented a methodology for the efficient recovery of acid‐eluted HLA peptides after purification with the pan‐reactive antibody W6/32 and have identified a total of 27 862 unique peptides with high confidence (1% false discovery rate) from five human cancer cell lines. More than 93% of the identified peptides were eight to 11 amino acids in length and contained signatures that were in excellent agreement with published HLA binding motifs. Furthermore, by purifying soluble HLA class I complexes (sHLA) from sera of melanoma patients, up to 972 high‐confidence peptides could be identified, including melanoma‐associated antigens already described in the literature. Knowledge of the HLA class I peptidome should facilitate multiplex tetramer technology‐based characterization of T cells, and allow the development of patient selection, stratification and immunomodulatory therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ritz et al.63 reported that the separation of MHC heavy chain, β2m, and peptides by reversed-phase LC4,22,62,65 yielded more peptides than an ultrafiltration without organic solvent.”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974 · cited 1×
“Recent evidence suggests that mutated HLA peptides are important determinants of response to immunotherapy [7, 8, 46].”
Backgroundvan Rooij, N., van Buuren, M. M., Philips, D., Velds, A., Toebes, M., Heemskerk, B., van Dijk, L. J. A., Behjati, S., Hilkmann, H., el Atmioui, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.7521 · Cited by 798 · cited 1×
“Recent evidence suggests that mutated HLA peptides are important determinants of response to immunotherapy [7, 8, 46].”
BackgroundMichalski, A., Cox, J., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101060v · Cited by 685
Mohammed, F., Cobbold, M., Zarling, A. L., Salim, M., Barrett-Wilt, G. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., & Willcox, B. E. (2008) · Nature Immunology · doi:10.1038/ni.1660 · Cited by 155 · cited 1×
“5% of all phosphorylations were found at position P4, which is in line with a recent publication indicating that a phosphate at this position can interact with arginine 65 of the HLA-A*02:01 alpha chain [34].”
BackgroundEfficient peptide recovery from secreted recombinant MHC-I molecules expressed via mRNA transfection
Lazarus, D., Weinstein-Marom, H., Fishman, S., Yossef, R., Zuri, D., Barnea, E., Admon, A., Margalit, A., & Gross, G. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.03.008 · Cited by 7
Research works printed but not linked: 42
- 10.1038/nature12477 · DOI · Paper page
- 10.1038/emboj.2012.333 · DOI · Paper page
- 10.1016/j.coi.2013.03.007 · DOI
- 10.1126/science.aaa8172 · DOI · Paper page
- 10.1158/0008-5472.CAN-11-2614 · DOI · Paper page
- 10.1126/scitranslmed.3008918 · DOI · Paper page
- 10.1158/1078-0432.CCR-14-0433 · DOI · Paper page
- 10.1126/science.1319610 · DOI · Paper page
- 10.1007/BF00172063 · DOI · Paper page
- 10.4049/jimmunol.172.5.2944 · DOI · Paper page
- 10.1126/science.7513441 · DOI · Paper page
- 10.1172/JCI67388 · DOI
- 10.1586/14789450.3.6.653 · DOI
- 10.1074/mcp.M114.042812 · DOI · Paper page
- 10.1074/mcp.M112.024810 · DOI · Paper page
- 10.1002/eji.201545930 · DOI · Paper page
- 10.1007/s002510050219 · DOI
- 10.1016/j.molimm.2012.02.117 · DOI · Paper page
- 10.1073/pnas.1008501107 · DOI · Paper page
- Weidanz J. A., 2015, Detection of human leukocyte antigen biomarkers in breast cancer utilizing label‐free biosensor technology, J. Vis. Exp., 97, e52159
- 10.1126/science.aaa4971 · DOI · Paper page
- Zamo A., 2006, Establishment of the MAVER‐1 cell line, a model for leukemic and aggressive mantle cell lymphoma, Haematologica, 91, 40
- 10.1038/nbt.1511 · DOI · Paper page
- 10.1002/pmic.200900634 · doi:10.1002/pmic.200900634
- 10.1371/journal.pone.0000796 · DOI · Paper page
- 10.1093/bioinformatics/bts621 · DOI
- Rapin N., 2010, Current protocols in immunology
- 10.4049/jimmunol.1401689 · doi:10.4049/jimmunol.1401689
- 10.1016/0092-8674(78)90296-9 · DOI · Paper page
- 10.1111/tan.12095 · doi:10.1111/tan.12095
- 10.1074/mcp.M113.034314 · DOI · Paper page
- 10.1073/pnas.1321458111 · DOI · Paper page
- 10.1136/ard.55.4.268 · DOI · Paper page
- 10.1111/j.0001-2815.2004.00220.x · DOI
- Ugrinovic S., 1997, A single nonamer from the Yersinia 60‐kDa heat shock protein is the target of HLA‐B27‐restricted CTL response in Yersinia‐induced reactive arthritis, J. Immunol., 159, 5715, 10.4049/jimmunol.159.11.5715 · doi:10.4049/jimmunol.159.11.5715
- 10.1002/art.27257 · DOI
- 10.4161/21624011.2014.954893 · DOI
- 10.1038/nm.2883 · DOI · Paper page
- 10.1002/prca.201500054 · DOI
- 10.1016/j.drudis.2012.01.007 · DOI
- 10.1016/j.ccell.2014.12.004 · DOI
- 10.18632/oncotarget.6960 · DOI · Paper page
Cited by
O’Donnell, T. J., Rubinsteyn, A., & Laserson, U. (2020) · Cell Systems · doi:10.1016/j.cels.2020.06.010 · Cited by 440
Intron retention is a source of neoepitopes in cancer
Smart, A. C., Margolis, C. A., Pimentel, H., He, M. X., Miao, D., Adeegbe, D., Fugmann, T., Wong, K.-K., & Van Allen, E. M. (2018) · Nature Biotechnology · doi:10.1038/nbt.4239 · Cited by 322
Self-citationSturm, T., Sautter, B., Wörner, T. P., Stevanović, S., Rammensee, H.-G., Planz, O., Heck, A. J. R., & Aebersold, R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00386 · Cited by 63
Proteins and Proteoforms: New Separation Challenges
Regnier, F. E., & Kim, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05007 · Cited by 36
Metadata
- Authors
- Ritz, D., Gloger, A., Weide, B., Garbe, C., Neri, D., & Fugmann, T.
- Affiliations
- Philochem AG Otelfingen Switzerland
- Institute of Pharmaceutical Sciences, ETH Zurich Zurich Switzerland
- Department of Dermatology Division of Dermatologic Oncology Eberhard‐Karls‐University Tuebingen Germany
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2016-05
- Volume
- 16
- Issue
- 10
- Pages
- 1570-1580
- ISSN
- 1615-9853
- 1615-9861
- Cited by
- 61
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.